Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-04 English
Rules of the New Share Option Scheme
Share Issue/Capital Change Classification · 1% confidence The document is the full set of rules for a company’s Share Option Scheme – a detailed equity incentive plan governing grant, exercise, vesting and administration of share options. It is not a financial report, earnings release, proxy statement, nor a mere announcement. Instead, it sets out the mechanics of issuing new shares under the option scheme, fitting the category of capital structure changes. Therefore, it should be classified as a Share Issue/Capital Change (SHA).
2026-04-27 English
Notification Letter and Request Form to Non-Registered Shareholders
Report Publication Announcement Classification · 1% confidence The document is a notification letter dated 28 April 2026 from Uni-Bio Science Group Limited to non-registered shareholders, informing them of the publication of a Circular (relating to termination and adoption of share option schemes and an Extraordinary General Meeting notice) on the Company’s and HKEX websites. It provides instructions for requesting printed versions. This is not the Circular itself but a notice of publication of corporate communications, fitting the definition of a Report Publication Announcement (RPA).
2026-04-27 English
Notification Letter and Reply Form to Registered Shareholders
Report Publication Announcement Classification · 1% confidence The document is a notification letter to registered shareholders informing them that the Company’s circular (relating to termination and adoption of share option schemes, notice of EGM, and proxy form) is now published on the Company and HKEX websites, and includes a reply form for electing printed or electronic delivery. It does not contain the circular itself or financial data but merely announces its publication and availability online. Under the ‘Menu vs Meal’ rule, this is an announcement of a report rather than the report itself, matching the definition of a Report Publication Announcement.
2026-04-27 English
FORM OF PROXY
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for an Extraordinary General Meeting, used to solicit shareholder voting instructions rather than reporting results or announcing management changes. This falls squarely under Proxy Solicitation & Information Statement, where proxies and voting materials are distributed to shareholders for a general meeting.
2026-04-27 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Notice of Extraordinary General Meeting (EGM) of Uni-Bio Science Group, detailing meeting purpose, resolutions to be voted on (new share option scheme, termination of existing scheme, service provider sublimit), proxy appointment instructions, record date, and other meeting details. It is a meeting notice and solicitation of shareholder votes, fitting the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.